Decreased cerebrospinal fluid levels of neurosin (KLK6), an aging-related protease, as a possible new risk factor for Alzheimer's disease.
- 1 November 2002
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 977 (1) , 216-223
- https://doi.org/10.1111/j.1749-6632.2002.tb04818.x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Activity of a newly identified serine protease in CNS demyelinationBrain, 2002
- Biochemical markers related to Alzheimer’s dementia in serum and cerebrospinal fluidNeurobiology of Aging, 2002
- Elevated levels of phosphorylated neurofilament proteins in cerebrospinal fluid of Alzheimer disease patientsNeuroscience Letters, 2002
- Enzymatic Properties of Rat Myelencephalon-Specific ProteaseBiochemistry, 2001
- The Spectrum of Human Kallikrein 6 (Zyme/Protease M/Neurosin) Expression in Human Tissues as Assessed by ImmunohistochemistryJournal of Histochemistry & Cytochemistry, 2001
- Cerebrospinal Fluid Tau Levels Increase with Age in Healthy IndividualsDementia and Geriatric Cognitive Disorders, 2001
- Human Kallikrein 6 as a Biomarker of Alzheimer’s DiseaseClinical Biochemistry, 2000
- Localization of a novel type trypsin‐like serine protease, neurosin, in brain tissues of Alzheimer's disease and Parkinson's diseasePsychiatry and Clinical Neurosciences, 2000
- A Novel Isoform of a Kallikrein-like Protease, TLSP/Hippostasin, (PRSS20), Is Expressed in the Human Brain and ProstateBiochemical and Biophysical Research Communications, 2000
- Molecular cloning of a novel trypsin-like serine protease (neurosin) preferentially expressed in brainBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1997